Research Projects- CAMP
CAMP
CAMP invents and demonstrates these CQA/PAT capabilities:
-
From stem to immune cells
-
Addressing ailments ranging from cancer to tissue degeneration
-
Targeting adherent and suspended cells, with and without genetic engineering
-
Leveraging deep and growing collaborations in Singapore and at MIT
Our goal is that this applied research and the new workforce that develops with and for the manufacturing industry & clinics will provide more patients with access to promising, approved therapies.
Flagship Project 1
Label-free critical quality attributes for personalised efficacy of cell therapies, including multivariate analysis of biological and biophysical attributes
Flagship Project 2
Rapid critical quality attributes for the safety of cell sources and cell therapy products, informing process analytic technologies and speeding product release
Flagship Project 3
PAT for cell proliferation and recovery, including inline and intermittent monitoring to promote efficacy and safety attributes for timely cell product release
